HEATHER BOYLE: Open Payments
NPI 1245740315 · KENNEWICK, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 29 payments from 10 companies in 2025. Trend: 2023 $461 · 2024 $660 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $231 |
| ABBVIE INC. | 10 | $225 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $56 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $23 |
| Lilly USA, LLC | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| PFIZER INC. | 1 | $16 |
Products named: UBRELVY, QULIPTA, Kerendia, JARDIANCE, INSPIRE, The Cologuard Plus Collection Kit, MOUNJARO, TRELEGY ELLIPTA.
Industry payments across WA — which companies pay providers there.
